Clinical trial
Safety Study of a Vaccine Against Meningitis in Infants ( 2,4 & 6 Months Age)…
NCT00317135 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00317135 |
|---|---|
| Title | Safety Study of a Vaccine Against Meningitis in Infants ( 2,4 & 6 Months Age) After a Birth Dose of Hepatitis B. |
| Official title | Assess Reactogenicity and Safety of GSK Biologicals' Tritanrix™-HepB/Hib-MenAC Compared to Tritanrix™-HepB/Hiberix™ (Control) in Healthy Infants (2,4,6 Months Age), After a Hepatitis B Birth Dose |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diphtheria, Hepatitis B, Whole Cell Pertussis, Haemophilus Influenzae Type b, Tetanus |
| Intervention type | Biological |
| Interventions | Tritanrix-HepB/Meningitec conjugate vaccine, Tritanrix/Hiberix vaccine |
| Enrollment | 500 |
| Start date | Dec 11, 2003 |
| Primary completion | Oct 23, 2004 |
| Completion | Oct 23, 2004 |
| First posted | Apr 24, 2006 |
| Last update posted | Aug 15, 2018 |
| Countries | Philippines |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: